Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (241-250 of 415) with videos related to

Pageof 42
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral TherapyBernard Surial, Frédérique Chammartin, José Damas, et al.
The Journal of Infectious Diseases|February 16, 2022
Impact of Latent Tuberculosis on DiabetesBurcu Tepekule, Katharina Kusejko, Marius Zeeb, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 1, 2024
Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral TherapyTeja Turk, Marco Labarile, Dominique L Braun, et al.
Plos One|November 29, 2012
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimensAlexandra U Scherrer, Jürg Böni, Sabine Yerly, et al.
Journal of the International AIDS Society|November 21, 2015
Reasons for late presentation to HIV care in SwitzerlandAnna Hachfeld, Bruno Ledergerber, Katharine Darling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2024
HIV-1 low-level viremia predicts viral failure in participants on antiretroviral therapy in the Swiss HIV Cohort StudyCaroline Lanz, Jan Meier, Marcel Stöckle, et al.
Plos One|December 30, 2011
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and SwitzerlandFranziska Schöni-Affolter, Olivia Keiser, Albert Mwango, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2019
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged PatientsIrene A Abela, Alexandra U Scherrer, Jürg Böni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2013
Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort studyAnna Conen, Qing Wang, Tracy R Glass, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral TreatmentAshima Pyngottu, Alexandra U Scherrer, Roger Kouyos, et al.
Pageof 42

Showing results (241-250 of 415) with videos related to

Sort By:
Pageof 42
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral TherapyBernard Surial, Frédérique Chammartin, José Damas, et al.
The Journal of Infectious Diseases|February 16, 2022
Impact of Latent Tuberculosis on DiabetesBurcu Tepekule, Katharina Kusejko, Marius Zeeb, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 1, 2024
Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral TherapyTeja Turk, Marco Labarile, Dominique L Braun, et al.
Plos One|November 29, 2012
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimensAlexandra U Scherrer, Jürg Böni, Sabine Yerly, et al.
Journal of the International AIDS Society|November 21, 2015
Reasons for late presentation to HIV care in SwitzerlandAnna Hachfeld, Bruno Ledergerber, Katharine Darling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2024
HIV-1 low-level viremia predicts viral failure in participants on antiretroviral therapy in the Swiss HIV Cohort StudyCaroline Lanz, Jan Meier, Marcel Stöckle, et al.
Plos One|December 30, 2011
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and SwitzerlandFranziska Schöni-Affolter, Olivia Keiser, Albert Mwango, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2019
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged PatientsIrene A Abela, Alexandra U Scherrer, Jürg Böni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2013
Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort studyAnna Conen, Qing Wang, Tracy R Glass, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral TreatmentAshima Pyngottu, Alexandra U Scherrer, Roger Kouyos, et al.
Pageof 42